These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Juvenile dermatomyositis: treatment with intravenous gammaglobulin.
    Author: Collet E, Dalac S, Maerens B, Courtois JM, Izac M, Lambert D.
    Journal: Br J Dermatol; 1994 Feb; 130(2):231-4. PubMed ID: 7510124.
    Abstract:
    High-dose intravenous gammaglobulin (IVGG) has proved to be effective in the treatment of a number of immune disorders. We report two patients with juvenile dermatomyositis (DM) who improved with IVGG therapy. These patients had become refractory to corticosteroids and had developed unacceptable steroid toxicity. We suggest that IVGG can be useful in the treatment of juvenile DM, by reducing steroid requirements, and replacing immunosuppressive drugs.
    [Abstract] [Full Text] [Related] [New Search]